Dermatovenerologiya va estetik tibbiyot

45
Дерматовенерология и эстетическая меДицина № 3/2015
arthritis, Dermatology life Quality Index (DlQI), 
Psoriatic arthritis Quality of life (PsaQOl), 
Functional assessment of Chronic Illness 
Therapy-Fatigue (FaCIT-F), Psoriatic arthritis 
response Criteria (PsarC), Psoriatic arthritis 
joint activity Index (PsajaI), Disease activity 
in Psoriatic arthritis (DaPSa), and Composite 
Psoriatic Disease activity Index (CPDaI). arthritis 
Care res (Hoboken). 2011;63(Suppl. 11):S64–85.
76. moll j.m.H., Wright V. Psoriatic arthritis // Semin. 
arthr. rheum. 1973;3;55–78.
77. molto a. et al. Evaluation of the validity of the 
different arms of the aSaS set of criteria for 
axial spondyloarthritis and description of the 
different imaging abnormalities suggestive of 
spondyloarthritis: data from the DESIr cohort 
ann rheum Dis. 2015;74;746–751. 
78. Olivieri I., Padula a., D’angelo S., Cutro m.S. 
Psoriatic arthritis sine psoriasis // j rheumatol. 
2009;Suppl. 83;28.
79. Palominos P.E., Gaujoux-Viala C., Fautrel b. 
et al. Clinical outcomes in psoriatic arthritis: a 
systematic literature review // arthritis Care res 
(Hoboken). 2012;64;397–406.
80. Philip j. mease psoriatic arthritis: update on 
pathophysiology, assessment and management 
ann rheum Dis. 2011;70 (Suppl. 1);i77–i84. 
81. Poggenborg r.P. et al. Enthesitis in patients 
with psoriatic arthritis, axial spondyloarthritis 
and healthy subjects assessed by ‘head-to-toe’ 
whole-body mrI and clinical examination // ann 
rheum Dis. 2015;74;823–829. 
82. ritchlin C.T., Kavanaugh a., Gladman D.D. et al. 
Treatment recommendations for psoriatic arthritis 
// ann rheum Dis. 2009;68;1387–94.
83. reis a. et. al. review of the use of ultrasound 
for the Diagnosis and monitoring of Enthesitisin 
Psoriatic arthritis // Curr. rheumatol. rep. 2011.
Vol. 10. 
84. Scarpa r., Cuocolo a., Peluso r. et al. 
Early psoriatic arthritis: the clinical spectrum 
// j. rheumatol. 2008;35;137–41. Sherlock 
j.P., joyce-Shaikh b., Turner S.P. et al. Il-23 
induces spondyloarthropathy by acting on rOr_
gammat+ CD3+CD4_CD8_ entheseal resident T 
cells // nat med. 2012;18;1069–76. 
85. Salvarani C. et al. Prevalence of psoriatic 
arthritisin Italian psoriatic patients // j rheumatol. 
1995; 22;1499–503.
86. Salvarani C., Cantini F., Olivieri I. et al. Isolated 
peripheral enthesitis and/or dactylitis: a subset of 
psoriaticarthritis // j. rheumatol. 1997;24(6);1106.
87. Shang Q., Tam l.S., yip G.W. et al. High 
prevalence of subclinical left Ventricular 
dysfunction in patients with psoriatic arthritis // j. 
rheumatol. 2011. 
88. Sorensen j. et al. Diagnostic delay in patients 
with rheumatoid arthritis, psoriatic arthritis and 
ankylosing spondylitis: results from the Danish 
nationwide DanbIO registry ann rheum dis. 
2015;74:e12. 
89. Tam l.S., Tomlinson b., Chu T.T. et al. 
Cardiovascular risk proile of patients with 
psoriatic arthritis compared to controls — the role 
of inflammation // rheumatology (Oxford). 2008; 
47;718–23.
90. Fitzgerald O., Winchester r. Psoriatic arthritis: 
from pathogenesis to therapy // arthritis res 
Ther. 2009;11;214.
91. Fitz Gerald O., Helliwell P., mease P. et al. 
application of composite disease activity scores 
in psoriatic arthritis to the PrESTa data set 
// ann rheum Dis. 2012;71(3);358–62. 
92. Weger W. an update on the diagnosis and 
management of psoriatic arthritis // GItal 
Dermatol Venereol. 2011;146(1);1–8.

---